Bristol-Myers Squibb To Sell Australian Manufacturing Facility To Generics Maker Sigma

PERTH, Australia - Bristol-Myers Squibb revealed Sept. 7 that it plans to sell its Australian manufacturing facility in Melbourne to generic drug maker Sigma Pharmaceuticals for roughly AU$60 million. The Melbourne-based plant is the only production facility held by BMS in Australia